Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

18.4K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
18.4K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.6K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

5.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.9K
Mitochondrial Membranes01:45

Mitochondrial Membranes

16.6K
A single mitochondrion is a bean-shaped organelle enclosed by a double-membrane system. The outer membrane of mitochondria is smooth and contains many porins - the integral membrane transporters. Porins enable free diffusion of ions and small uncharged molecules through the outer mitochondrial membrane but limit the transport of molecules larger than 5000 Daltons. Further, the outer mitochondrial membrane forms a unique structure called membrane contact sites with other subcellular organelles,...
16.6K
Drugs that Stabilize Microtubules01:15

Drugs that Stabilize Microtubules

2.6K
Microtubules are dynamic structures that undergo cycles of catastrophe and rescue. The microtubules play a central role in cell division by forming the spindle apparatus for segregating the chromosomes. This makes them ideal targets for regulating dividing cells in tumors and malignant cancer cells. Microtubule stabilizing drugs help stabilize the microtubule formation and promote its polymerization. Paclitaxel was the first microtubule stabilizing agent used as anticancer drug in chemotherapy...
2.6K
Drugs that Destabilize Microtubules01:10

Drugs that Destabilize Microtubules

3.6K
Microtubules are dynamic structures and can be regulated by microtubule targeting agents (MTAs). Microtubule destabilizing drugs are a class of MTAs that destabilize and prevent microtubules' polymerization. Both natural and synthetic chemicals can be found under this class of drugs. Vincristine and vinblastine, two vinca alkaloids, and colchicine were among the first to be discovered. These drugs can affect cells in various ways, either by inducing a change in cell morphology, preventing...
3.6K

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Ensemble molecular dynamics for predicting binding energies of DNA intercalators.

RSC advances·2026
Same author

BRITE-338733: From RecA inhibition to cancer treatment.

European journal of medicinal chemistry·2025
Same author

Rapid and Accurate Estimation of Quantum Average Electron Densities Using Newly-Defined Atom Types.

ACS omega·2025
Same author

The Average Electron Density Tool for Bioisosterism in Hydrophobic Media.

ACS omega·2025
Same author

Quantum Evaluation of a Comprehensive Set of Carboxylic Acid Bioisosteres: Gas versus Solvated Phases.

ACS omega·2025
Same author

Accurate prediction of DNA-Intercalator binding energies: Ensemble of short or long molecular dynamics simulations?

International journal of biological macromolecules·2025

関連する実験動画

Updated: Jan 14, 2026

Author Spotlight: Transmitochondrial Cybrid Generation Using Cancer Cell Lines
07:49

Author Spotlight: Transmitochondrial Cybrid Generation Using Cancer Cell Lines

Published on: March 17, 2023

3.1K

がん治療のためのミトコンドリア複合体の標的化

Alaa M A Osman1, Alya A Arabi1

  • 1College of Medicine and Health Sciences, Department of Biochemistry and Molecular Biology, United Arab Emirates University, AlAin, P. O. Box: 15551, United Arab Emirates.

Biochemical pharmacology
|January 12, 2026
PubMed
まとめ

ミトコンドリア電子伝達鎖(ETC)複合体の標的化は、がん細胞のエネルギー産生を破壊することにより、がん治療のための新しい戦略を提供する。このレビューでは、ETC阻害、生物エネルギー学的破壊、およびAIやナノメディシンを含む高度な治療アプローチを探る。

背景:

  • ミトコンドリア電子伝達鎖(ETC)複合体I-IVは、がん細胞のエネルギーおよび生合成に不可欠です。
  • これらの複合体の阻害は、がん細胞の生存をブロックするための有望な戦略です。

研究 の 目的:

  • がん治療のためのETC複合体阻害に関する現在の知見をレビューすること。
  • 生物エネルギー学的破壊および光線力学療法(PDT)などの新しい治療戦略を探求すること。
  • ETC標的がん治療薬の開発におけるAIおよびナノテクノロジーの役割を強調すること。

主な方法:

  • ETC複合体阻害に関するin silico、in vitro、およびin vivo研究をレビューしました。
  • 生物エネルギー学的破壊メカニズムの分析。
  • PDT、低分子、再利用薬、AI、およびナノテクノロジーを含む治療戦略の探求。

主要な成果:

  • ETC複合体の阻害は、がん細胞の生存を効果的にブロックします。
  • 光線力学療法(PDT)およびその他の新しい戦略が有望です。
  • AIおよびナノテクノロジーは、ETC標的抗がん剤の発見を加速できます。
  • ETC複合体の標的化は、精密医療に統合できます。

結論:

  • ミトコンドリアETC複合体は、新しい抗がん剤を開発するための実行可能な標的です。
キーワード:
人工知能がん創薬電子伝達鎖ミトコンドリア酸化的リン酸化

さらに関連する動画

An Automated Differential Nuclear Staining Assay for Accurate Determination of Mitocan Cytotoxicity
07:58

An Automated Differential Nuclear Staining Assay for Accurate Determination of Mitocan Cytotoxicity

Published on: May 12, 2020

7.4K
Experimental Approaches to Study Mitochondrial Localization and Function of a Nuclear Cell Cycle Kinase, Cdk1
13:15

Experimental Approaches to Study Mitochondrial Localization and Function of a Nuclear Cell Cycle Kinase, Cdk1

Published on: February 25, 2016

12.4K

関連する実験動画

Last Updated: Jan 14, 2026

Author Spotlight: Transmitochondrial Cybrid Generation Using Cancer Cell Lines
07:49

Author Spotlight: Transmitochondrial Cybrid Generation Using Cancer Cell Lines

Published on: March 17, 2023

3.1K
An Automated Differential Nuclear Staining Assay for Accurate Determination of Mitocan Cytotoxicity
07:58

An Automated Differential Nuclear Staining Assay for Accurate Determination of Mitocan Cytotoxicity

Published on: May 12, 2020

7.4K
Experimental Approaches to Study Mitochondrial Localization and Function of a Nuclear Cell Cycle Kinase, Cdk1
13:15

Experimental Approaches to Study Mitochondrial Localization and Function of a Nuclear Cell Cycle Kinase, Cdk1

Published on: February 25, 2016

12.4K
  • 生物エネルギー学的破壊、革新的な治療法、およびAI主導のアプローチの組み合わせは、がん治療を強化できます。
  • 精密医療戦略は、個別化がん治療のためにETCの依存性を活用できます。